Junwei Wei

ORCID: 0000-0003-1874-203X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • RNA modifications and cancer
  • Ferroptosis and cancer prognosis
  • Epigenetics and DNA Methylation
  • Natural product bioactivities and synthesis
  • Immune cells in cancer
  • Microbial Natural Products and Biosynthesis
  • Phytochemical compounds biological activities

Hebei Medical University
2021-2022

Third Hospital of Hebei Medical University
2021-2022

Solute Carrier Family 38 Member 1 (SLC38A1) is a principal transporter of glutamine and plays crucial role in the transformation neoplastic cells. However, correlation between SLC38A1 expression, prognosis, immune infiltration hepatocellular carcinoma (HCC) has yet to be elucidated. We used two independent patient cohorts, namely, Cancer Genome Atlas (TCGA) cohort Clinical Proteomic Tumor Analysis Consortium (CPTAC) cohort, analyze HCC at mRNA protein levels, respectively. In these...

10.1155/2021/5680968 article EN Journal of Oncology 2021-10-16

Background and aims: The exact function of Phosphatidylinositol Glycan Anchor Biosynthesis, Class C (PIGC) gene has yet to be elucidated. In the study, we attempted clarify correlations PIGC prognosis tumor-infiltrating lymphocytes in hepatocellular carcinoma (HCC). Methods: expression was analyzed via Oncomine database, Gene Expression Profiling Interactive Analysis, Hepatocellular data base, Human Protein Atlas database Tumor Immune Estimation Resource (TIMER). We showed correlation with...

10.3389/fgene.2022.899407 article EN cc-by Frontiers in Genetics 2022-08-19
Coming Soon ...